Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children Liquid Dosage Form Therapy in Infants With Sequelae of Perinatal Brain Injury

NCT03159611 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT03159611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03159611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children Liquid Dosage Form Therapy in Infants With Sequelae of Perinatal Brain Injury
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Completed
Start date
February 19, 2016
Completion date
February 9, 2018
Enrollment
182 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

sequelae of perinatal brain injury